Periodic screening of donor faeces with a quarantine period to prevent transmission of multidrug-resistant organisms during faecal microbiota transplantation: a retrospective cohort study

Duodenal Infusion of Donor Feces for Recurrent <i>Clostridium difficile</i>

van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708 · see citing works

Drug-Resistant <i>E. coli</i> Bacteremia Transmitted by Fecal Microbiota Transplant

DeFilipp, Z., Bloom, P. P., Torres Soto, M., Mansour, M. K., Sater, M. R. A., Huntley, M. H., Turbett, S., Chung, R. T., Chen, Y.-B., & Hohmann, E. L. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1910437 · Cited by 1,281 · see citing works

International consensus conference on stool banking for faecal microbiota transplantation in clinical practice

Cammarota, G., Ianiro, G., Kelly, C. R., Mullish, B. H., Allegretti, J. R., Kassam, Z., Putignani, L., Fischer, M., Keller, J. J., Costello, S. P., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-319548 · Cited by 506 · see citing works

Import and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study

Arcilla, M. S., van Hattem, J. M., Haverkate, M. R., Bootsma, M., van Genderen, P. J. J., Goorhuis, A., Grobusch, M. P., Lashof, A. M. L. O., Molhoek, N., Schultsz, C., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30319-x · Cited by 465 · see citing works

The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications.

Allegretti, J. R., Mullish, B. H., Kelly, C., & Fischer, M. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31266-8 · Cited by 358 · see citing works

The Effects of Freezing on Faecal Microbiota as Determined Using MiSeq Sequencing and Culture-Based Investigations

Fouhy, F., Deane, J., Rea, M. C., O’Sullivan, Ó., Ross, R. P., O'Callaghan, G. P., Plant, B. J., & Stanton, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119355 · Cited by 310 · see citing works

Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening

Zhang, T., Lu, G., Zhao, Z., Liu, Y., Shen, Q., Li, P., Chen, Y., Yin, H., Wang, H., Marcella, C., et al. (2020) · Protein & Cell · doi:10.1007/s13238-019-00684-8 · Cited by 262 · see citing works

Fecal Microbial Transplants Reduce Antibiotic-resistant Genes in Patients With Recurrent Clostridium difficile Infection

Millan, B., Park, H., Hotte, N., Mathieu, O., Burguière, P., Tompkins, T. A., Kao, D. H., & Madsen, K. L. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw185 · Cited by 218 · see citing works

Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in Amsterdam

Reuland, E. A., al Naiemi, N., Kaiser, A. M., Heck, M. E. O. C., Kluytmans, J. A. J. W., Savelkoul, P. H. M., Elders, P. J. M., & Vandenbroucke‐Grauls, C. M. J. E. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv441 · Cited by 169 · see citing works

How to: establish and run a stool bank

Terveer, E. M., van Beurden, Y. H., Goorhuis, A., Seegers, J. F. M. L., Bauer, M. P., van Nood, E., Dijkgraaf, M. G. W., Mulder, C. J. J., Vandenbroucke-Grauls, C. M. J. E., Verspaget, H. W., et al. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.05.015 · Cited by 168 · see citing works

Extended-Spectrum β-Lactamase–producingEnterobacteriaceaeamong Travelers from the Netherlands

Paltansing, S., Vlot, J. A., Kraakman, M. E. M., Mesman, R. L. S., Bruijning, M. L., Bernards, A. T., Visser, L. G., & Veldkamp, K. E. (2013) · Emerging infectious diseases · doi:10.3201/eid.1908.130257 · Cited by 138 · see citing works

Extended-Spectrum β-Lactamase–producingEnterobacteriaceaeamong Travelers from the Netherlands

Paltansing, S., Vlot, J. A., Kraakman, M. E. M., Mesman, R. L. S., Bruijning, M. L., Bernards, A. T., Visser, L. G., & Veldkamp, K. E. (2013) · Emerging infectious diseases · doi:10.3201/eid1908.130257 · Cited by 133 · see citing works

Donor Screening for Fecal Microbiota Transplantation

Kassam, Z., Dubois, N. E., Ramakrishna, B., Ling, K., Qazi, T., Smith, M. B., Kelly, C. R., Fischer, M., Allegretti, J. R., Budree, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmc1913670 · Cited by 127 · see citing works

Prevalence, risk factors and genetic characterisation of extended-spectrum beta-lactamase and carbapenemase-producing Enterobacteriaceae (ESBL-E and CPE): a community-based cross-sectional study, the Netherlands, 2014 to 2016

van den Bunt, G., van Pelt, W., Hidalgo, L., Scharringa, J., de Greeff, S. C., Schürch, A. C., Mughini‐Gras, L., Bonten, M. J. M., & Fluit, A. C. (2019) · Eurosurveillance · doi:10.2807/1560-7917.es.2019.24.41.1800594 · Cited by 96 · see citing works

Prevalence of extended-spectrum β-lactamase-producing Enterobacteriaceae in humans living in municipalities with high and low broiler density

Huijbers, P. M. C., de Kraker, M. E. A., Graat, E. A. M., van Hoek, A. H. A. M., Santen, M. G. V., de Jong, M. C. M., van Duijkeren, E., & de Greeff, S. C. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12150 · Cited by 89 · see citing works

Extended Spectrum Beta-Lactamase-Producing Enterobacteriaceae in International Travelers and Non-Travelers in New York City

Weisenberg, S. A., Mediavilla, J. R., Chen, L., Alexander, E. L., Rhee, K. Y., Kreiswirth, B. N., & Jenkins, S. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045141 · Cited by 71 · see citing works

Extended-spectrum β-lactamase- and pAmpC-producing Enterobacteriaceae among the general population in a livestock-dense area

Wielders, C. C. H., van Hoek, A. H. A. M., Hengeveld, P. D., Veenman, C., Dierikx, C. M., Zomer, T. P., Smit, L. A. M., van der Hoek, W., Heederik, D. J. J., de Greeff, S. C., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.10.013 · Cited by 71 · see citing works

Enrichment Broth Improved Detection of Extended-Spectrum-Beta-Lactamase-Producing Bacteria in Throat and Rectal Surveillance Cultures of Samples from Patients in Intensive Care Units

Murk, J., Heddema, E. R., Hess, D., Bogaards, J. A., Vandenbroucke‐Grauls, C. M. J. E., & Debets-Ossenkopp, Y. J. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01406-08 · Cited by 62 · see citing works

Reduction of Antibiotic Resistance Genes in Intestinal Microbiota of Patients With Recurrent Clostridium difficile Infection After Fecal Microbiota Transplantation

Jouhten, H., Mattila, E. J., Arkkila, P., & Satokari, R. M. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw390 · Cited by 47 · see citing works

Faecal freezing preservation period influences colonization ability for faecal microbiota transplantation

Takahashi, M., Ishikawa, D., Sasaki, T., Lu, Y., Kuwahara‐Arai, K., Kamei, M., Shibuya, T., Osada, T., Hiramatsu, K., & Nagahara, A. (2018) · Journal of Applied Microbiology · doi:10.1111/jam.14167 · Cited by 44 · see citing works

Fecal Transplant in Children With Clostridioides difficile Gives Sustained Reduction in Antimicrobial Resistance and Potential Pathogen Burden

Hourigan, S. K., Ahn, M., Gibson, K. M., Pérez‐Losada, M., Felix, G., Weidner, M., Leibowitz, I., Niederhuber, J. E., Sears, C. L., Crandall, K. A., et al. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz379 · Cited by 43 · see citing works

Current challenges in the treatment of severe Clostridium difficile infection: early treatment potential of fecal microbiota transplantation

van Beurden, Y. H., Nieuwdorp, M., van de Berg, P. J. E. J., Mulder, C. J. J., & Goorhuis, A. (2017) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x17690480 · Cited by 36 · see citing works

Importance of pre-enrichment for detection of third-generation cephalosporin-resistant Enterobacteriaceae (3GCREB) from rectal swabs

Jazmati, N., Jazmati, T., & Hamprecht, A. G. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3000-1 · Cited by 33 · see citing works

Comparison of 2 chromogenic media for the detection of extended-spectrum β-lactamase producing Enterobacteriaceae stool carriage in nursing home residents

Blane, B., Brodrick, H. J., Gouliouris, T., Ambridge, K., Kidney, A. D., Ludden, C., Limmathurotsakul, D., Török, M. E., & Peacock, S. J. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.11.008 · Cited by 20 · see citing works

Manipulation of the microbiota to eradicate multidrug-resistant Enterobacteriaceae from the human intestinal tract

Kuijper, E. J., Vendrik, K. E. W., & Vehreschild, J. J. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.03.025 · Cited by 17 · see citing works

Real-time sampling of travelers shows intestinal colonization by multidrug-resistant bacteria to be a dynamic process with multiple transient acquisitionsPreprint

Kantele, A., Kuenzli, E., Dunn, S. J., Dance, D. A. B., Newton, P. N., Davong, V., Mero, S., Pakkanen, S. H., Neumayr, A. L. C., Hatz, C., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/827915 · Cited by 10 · see citing works

European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults

van Prehn, J., Reigadas, E., Vogelzang, E. H., Bouza, E., Hristea, A., Guery, B., Krutova, M., Norén, T., Allerberger, F., Coia, J. E., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.09.038 · Cited by 640 · see citing works

Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies

(2022) · doi:10.1186/s13045-022-01273-9 · Cited by 495 · see citing works

Fecal microbiota transplantation: current challenges and future landscapes

Yadegar, A., Bar‐Yoseph, H., Monaghan, T. M., Pakpour, S., Severino, A., Kuijper, E. J., Smits, W. K., Terveer, E. M., Neupane, S., Nabavi-Rad, A., et al. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00060-22 · Cited by 379 · see citing works

Key determinants of success in fecal microbiota transplantation: From microbiome to clinic

Porcari, S., Benech, N., Valles-Colomer, M., Segata, N., Gasbarrini, A., Cammarota, G., Sokol, H., & Ianiro, G. (2023) · Cell Host &amp; Microbe · doi:10.1016/j.chom.2023.03.020 · Cited by 331 · see citing works

Gut microbiota shapes cancer immunotherapy responses

Lei, W., Zhou, K., Lei, Y., Li, Q., & Zhu, H. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00786-8 · Cited by 166 · see citing works

The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey

Baunwall, S. M. D., Terveer, E. M., Dahlerup, J. F., Erikstrup, C., Arkkila, P. E. T., Vehreschild, M. J. G. T., Ianiro, G., Gasbarrini, A., Sokol, H., Kump, P. K., et al. (2021) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2021.100181 · Cited by 100 · see citing works

Metabolic reprogramming in ischemic stroke: when glycolytic overdrive meets lipid storm

Wang, Y., Ge, M., Wang, J., Xu, Y., Wang, N., & Xu, S. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08114-w · Cited by 75 · see citing works

The role of the gut microbiota in tumor, immunity, and immunotherapy

Xie, Y., & Liu, F. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1410928 · Cited by 70 · see citing works

Antibiotics re-booted—time to kick back against drug resistance

Blaskovich, M. A. T., & Cooper, M. A. (2025) · npj Antimicrobials and Resistance · doi:10.1038/s44259-025-00096-1 · Cited by 59 · see citing works

Prevalence of Vancomycin-Resistant Enterococcus (VRE) in Companion Animals: The First Meta-Analysis and Systematic Review

Wada, Y., Irekeola, A., Engku Nur Syafirah, E. A. R., Yusof, W., Lee, L., Muhammad, S. L., Harun, A., Chan, Y.-A.-Y.-A., & Zaidah, A. (2021) · Antibiotics · doi:10.3390/antibiotics10020138 · Cited by 32 · see citing works

Gut–Liver–Pancreas Axis Crosstalk in Health and Disease: From the Role of Microbial Metabolites to Innovative Microbiota Manipulating Strategies

Marroncini, G., Naldi, L., Martinelli, S., & Amedei, A. (2024) · Biomedicines · doi:10.3390/biomedicines12071398 · Cited by 54 · see citing works

An update on fecal microbiota transplantation for the treatment of gastrointestinal diseases

Waller, K. M. J., Leong, R. W. L., & Paramsothy, S. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15731 · Cited by 49 · see citing works

Fecal Microbiota Transplantation during and Post-COVID-19 Pandemic

Kazemian, N., Kao, D. H., & Pakpour, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063004 · Cited by 41 · see citing works

Fine-tuning the gut ecosystem: the current landscape and outlook of artificial microbiome therapeutics

Porcari, S., Fusco, W. G., Spivak, I., Fiorani, M., Gasbarrini, A., Elinav, E., Cammarota, G., & Ianiro, G. (2024) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(23)00357-6 · Cited by 42 · see citing works

Harnessing gut microbiota for colorectal cancer therapy: from clinical insights to therapeutic innovations

Chen, C., Su, Q., Zi, M., Hua, X., & Zhang, Z. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00818-3 · Cited by 41 · see citing works

Long-term beneficial effect of faecal microbiota transplantation on colonisation of multidrug-resistant bacteria and resistome abundance in patients with recurrent Clostridioides difficile infection

Nooij, S., Vendrik, K. E. W., Zwittink, R. D., Ducarmon, Q. R., Keller, J. J., Kuijper, E. J., Terveer, E. M., & on behalf of the Netherlands Donor Feces Bank study group (2024) · Genome Medicine · doi:10.1186/s13073-024-01306-7 · Cited by 34 · see citing works

Fecal microbiota transplantation: application scenarios, efficacy prediction, and factors impacting donor-recipient interplay

Liu, Y., Li, X., Chen, Y., Yao, Q., Zhou, J., Wang, X., Meng, Q., Ji, J., Yu, Z., & Chen, X. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1556827 · Cited by 37 · see citing works

Fecal microbiota transplantation: present and future

Cha, R. R., & Sonu, I. S. (2025) · Clinical Endoscopy · doi:10.5946/ce.2024.270 · Cited by 31 · see citing works

Fecal Microbiota Transplantation Donor Screening Updates and Research Gaps for Solid Organ Transplant Recipients

Mehta, N., Wang, T. L., Friedman‐Moraco, R., Carpentieri, C., Mehta, A. K., Rouphael, N., Dhere, T., Larsen, C. P., Kraft, C. S., & Woodworth, M. H. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.00161-21 · Cited by 32 · see citing works

Gut microbiota dysbiosis and systemic immune dysfunction in critical ill patients with multidrug-resistant bacterial colonization and infection

Ling, Z., Ding, W., Liu, X., Zhang, J., Cheng, Y., Zhu, Z., Wu, L., Xu, X., Gao, Y., & Jiang, R. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07049-2 · Cited by 25 · see citing works

Probiotics and their metabolite spermidine enhance IFN-γ+CD4+ T cell immunity to inhibit hepatitis B virus

Wang, T., Fan, Y., Tan, S., Wang, Z., Li, M., Guo, X., Yu, X., Lin, Q., Song, X., Xu, L., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101822 · Cited by 21 · see citing works

Dissemination of carbapenemase-producing Enterobacterales through wastewater and gulls at a wastewater treatment plant in Sweden

Woksepp, H., Karlsson, K., Börjesson, S., Lindsjö, O. K., Söderlund, R., & Bonnedahl, J. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.163997 · Cited by 21 · see citing works

End-to-end donor screening and manufacturing controls: complementary quality-based strategies to minimize patient risk for donor-derived microbiome therapeutics

Goldsmith, J. R., Tomkovich, S., Aunins, J. G., McGovern, B., Mahoney, J. C., Hasson, B. R., McChalicher, C. W. J., & Ege, D. S. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2402550 · Cited by 22 · see citing works

Frontiers in antibiotic alternatives for Clostridioides difficile infection

Phanchana, M., Harnvoravongchai, P., Wongkuna, S., Phetruen, T., Phothichaisri, W., Panturat, S., Pipatthana, M., Charoensutthivarakul, S., Chankhamhaengdecha, S., & Janvilisri, T. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i42.7210 · Cited by 21 · see citing works

Donor screening for fecal microbiota transplantation with a direct stool testing-based strategy: a prospective cohort study

Rondinella, D., Quaranta, G., Rozera, T., D’Argenio, P., Fancello, G., Venturini, I., Guarnaccia, A., Porcari, S., Bibbò, S., Sanguinetti, M., et al. (2024) · Microbes and Infection · doi:10.1016/j.micinf.2024.105341 · Cited by 18 · see citing works

High carriage rate of extended‐spectrum β‐lactamase Enterobacterales and diarrheagenic Escherichia coli in healthy donor screening for fecal microbiota transplantation

Chuang, C., Lee, K., Wang, Y., Lee, P., Chang, T.-E., Huang, Y., Lin, Y.-T., & Hou, M. (2023) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-023-04644-3 · Cited by 16 · see citing works

Transmission of Antibiotic-Susceptible Escherichia coli Causing Urinary Tract Infections in a Fecal Microbiota Transplantation Recipient: Consequences for Donor Screening?

Vendrik, K. E. W., de Meij, T. G. J., Bökenkamp, A., Ooijevaar, R. E., Groenewegen, B., Hendrickx, A. P. A., Terveer, E. M., Kuijper, E. J., & van Prehn, J. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac324 · Cited by 14 · see citing works

Effect of microbiome group on immune checkpoint inhibitors in treatment of gastrointestinal tumors

Pei, B., Ma, X., Wu, N., Wang, C., & Yang, W. (2023) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2023.03.05 · Cited by 13 · see citing works

Stool donor screening within a Therapeutic Goods Administration compliant donor screening program for fecal microbiota transplantation

Tucker, E. C., Haylock‐Jacobs, S., Rapaic, M., Dann, L. M., Bryant, R. V., & Costello, S. P. (2023) · JGH Open · doi:10.1002/jgh3.12874 · Cited by 11 · see citing works

Towards optimising and standardising donor screening for faecal microbiota transplantion

Liu, C. S., Merrick, B., Taboun, Z. S., Mullish, B. H., Goldenberg, S. D., Terveer, E. M., Porcari, S., Bradbury, R. S., Ianiro, G., Ng, S. C., et al. (2025) · Gut · doi:10.1136/gutjnl-2025-336532 · Cited by 13 · see citing works

Use of proximity ligation shotgun metagenomics to investigate the dynamics of plasmids and bacteriophages in the gut microbiome following fecal microbiota transplantation

Bryson, S., Sisson, Z., Nelson, B., Grove, J., Reister, E., Liachko, I., Auch, B., Graiziger, C. T., & Khoruts, A. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2559019 · Cited by 8 · see citing works

Novel insights into pivotal risk factors for rectal carriage of extended-spectrum-β-lactamase-producing enterobacterales within the general population in Lower Saxony, Germany

Symanzik, C., Hillenbrand, J., Stasielowicz, L., Greie, J., Friedrich, A. W., Pulz, M., John, S. M., & Esser, J. (2021) · Journal of Applied Microbiology · doi:10.1111/jam.15399 · Cited by 8 · see citing works

Faecal microbiota transplantation: more screening for old and new pathogens

Hohmann, E. L. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30850-1 · Cited by 6 · see citing works

Fecal microbiota transplantation and its repercussions in patients with melanoma refractory to anti-PD-1 therapy: scope review

Barbosa, E. C., Bucar, E. E. C., JUBÉ, G. R., SILVEIRA, L. B., SILVA, N. C. D., FARIA, P. C. C., Ramos, P., Moraes, V. R. Y., & BARROS, J. O. B. (2023) · Revista do Colégio Brasileiro de Cirurgiões · doi:10.1590/0100-6991e-20233490-en · Cited by 4 · see citing works

Fecal Microbiota Transplantation as Emerging Treatment in European Countries 2.0

Porcari, S., Maida, M. F., Bibbò, S., Mcilroy, J. R., Ianiro, G., & Cammarota, G. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-42108-2_5 · Cited by 4 · see citing works

Roles of the gut microbiota in cancer immunotherapy: Mechanistic foundations and therapeutic opportunities

Wu, Q., Zhou, Y.-R., Chen, Z.-R., Liu, M.-X., Liu, M.-X., Liu, Y.-F., Li, Z., Zhao, Q.-R., Zhang, Y.-Q., Zhang, H., et al. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105230 · Cited by 4 · see citing works

Swiss expert opinion: current approaches in faecal microbiota transplantation in daily practice

Rossier, L., Matter, C., Burri, E., Galpérine, T., Hruz, P. L., Juillerat, P., Schoepfer, A. M., Vavricka, S. R., Zahnd, N., Décosterd, N., et al. (2023) · Swiss Medical Weekly · doi:10.57187/smw.2023.40100 · Cited by 3 · see citing works

Clostridioides difficile infection: a changing treatment paradigm

Al-Naser, Y., AlGashami, M., & Al-Jashaami, L. (2024) · Gastroenterology Review · doi:10.5114/pg.2024.136237 · Cited by 2 · see citing works

Double-edged sword: impact of fecal microbiome transplants on the gut resistome

Hallowell, H. A., Gao, A. L., & Suez, J. (2022) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000894 · Cited by 2 · see citing works

Transplante de microbiota fecal e suas repercussões em pacientes com melanoma refratário à terapia anti-PD-1: revisão de escopo

Barbosa, E. C., Bucar, E. E. C., JUBÉ, G. R., SILVEIRA, L. B., SILVA, N. C. D., FARIA, P. C. C., Ramos, P., Moraes, V. R. Y., & BARROS, J. O. B. (2023) · Revista do Colégio Brasileiro de Cirurgiões · doi:10.1590/0100-6991e-20233490 · Cited by 1 · see citing works

Long-term beneficial effect of faecal microbiota transplantation on colonisation of multidrug-resistant bacteria and resistome abundance in patients with recurrent Clostridioides difficile infectionPreprint

Nooij, S., Vendrik, K. E. W., Zwittink, R. D., Ducarmon, Q. R., Keller, J. J., Kuijper, E. J., & Terveer, E. M. (2023) · Qeios · doi:10.32388/1czvns · Cited by 1 · see citing works

Carriage rates of multidrug-resistant organisms among prospective stool donors

Zaman, A., Qazi, T., Pai, P., Peters, P., Nicolaysen, S., & Olesen, S. W. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00091-8

A Consortium of Fecal Microbes that Decolonizes Antibiotic-resistant Enteric Pathogens: A Potential Alternative to Fecal Microbiota TransplantationPreprint

Yoon, M. Y., Jeong, U. J., Cho, S. Y., Jung, H. Y., Kim, E. J., Rho, M., Han, M., Lee, E. H., Kim, J. H., Lee, S. S., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4818769/v1

Additional file 1 of Long-term beneficial effect of faecal microbiota transplantation on colonisation of multidrug-resistant bacteria and resistome abundance in patients with recurrent Clostridioides difficile infection

Nooij, S., Vendrik, K. E. W., Zwittink, R. D., Ducarmon, Q. R., Keller, J. J., Kuijper, E. J., & Terveer, E. M. (2024) · Figshare · doi:10.6084/m9.figshare.26686896

Additional file 2 of Long-term beneficial effect of faecal microbiota transplantation on colonisation of multidrug-resistant bacteria and resistome abundance in patients with recurrent Clostridioides difficile infection

Nooij, S., Vendrik, K. E. W., Zwittink, R. D., Ducarmon, Q. R., Keller, J. J., Kuijper, E. J., & Terveer, E. M. (2024) · Figshare · doi:10.6084/m9.figshare.26686899

Microbial Signals in Cancer: Dissecting Host–Microbiota–Tumor Interactions and Potential Therapeutic Strategy

Lu, J., Xuan, M., Yu, L., Xie, Z., Chu, Q., Wei, S., Wang, T., Xue, C., & Li, L. (2026) · MedComm · doi:10.1002/mco2.70994

Microbiome-Based Therapeutics in Oncology: Expanding Indications Beyond C. difficile

Al-Omari, A., Kheshman, A., Morkos, P., Davanzo, K., & Monday, L. (2026) · Onco · doi:10.3390/onco6030047

Fecal Microbiota Transplantation Beyond Clostridioides difficile Infection: Expanding Indications, Mechanisms, and Future Directions

Hasanuzzaman, M., Bang, C. S., Lee, J. J., & Gong, E. J. (2026) · Journal of Korean Medical Science · doi:10.3346/jkms.2026.41.e335

From the Gut–Liver Axis to the Gut–Liver–Immune–Transplant Continuum in MASLD

Gadour, E. (2026) · Journal of Translational Gastroenterology · doi:10.14218/jtg.2026.00035

Carriage rates of multidrug-resistant organisms among prospective stool donors

Zaman, A., Qazi, T., Pai, P., Peters, P., Nicolaysen, S., & Olesen, S. W. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00091-8

A necessary discussion after transmission of multidrug-resistant organisms through faecal microbiota transplantations

Kuijper, E. J., Allegretti, J. R., Hawkey, P. M., Sokol, H., Goldenberg, S. D., Ianiro, G., Gasbarrini, A., Kump, P. K., Costello, S. P., Keller, J. J., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30545-6 · Cited by 13 · see citing works

High carriage rate of extended‐spectrum β‐lactamase Enterobacterales and diarrheagenic Escherichia coli in healthy donor screening for fecal microbiota transplantation

Chuang, C., Lee, K., Wang, Y., Lee, P., Chang, T.-E., Huang, Y., Lin, Y.-T., & Hou, M. (2023) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-023-04644-3 · Cited by 16 · see citing works

Low Carriage Rates of Multidrug-Resistant Organisms in Prospective Stool Donors in a Large Fecal Microbiota Transplantation (FMT) Stool Bank

Zaman, A., Qazi, T., Pai, P., Peters, T., & Nicolaysen, S. (2020) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2020.580

Faecal microbiota transplantation: more screening for old and new pathogens

Hohmann, E. L. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30850-1 · Cited by 6 · see citing works